Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies

por Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu
Publicado 2021

Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies

por Huang, Bo-Cheng, Lu, Yun-Chi, Liao, Jun-Min, Liu, Hui-Ju, Hong, Shih-Ting, Hsieh, Yuan-Chin, Chuang, Chih-Hung, Chen, Huei-Jen, Liao, Tzu-Yi, Ho, Kai-Wen, Wang, Yeng-Tseng, Cheng, Tian-Lu
Publicado 2021

Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy

por Lin, Wen-Wei, Cheng, Yi-An, Li, Chia-Ching, Ho, Kai-Wen, Chen, Huei-Jen, Chen, I.-J.u, Huang, Bo-Cheng, Liu, Hui-Ju, Lu, Yun-Chi, Cheng, Chiu-Min, Huang, Ming-Yii, Lai, Hung-Wen, Cheng, Tian-Lu
Publicado 2021

Humanized bispecific antibody (mPEG × HER2) rapidly confers PEGylated nanoparticles tumor specificity for multimodality imaging in breast cancer

por Cheng, Yi-An, Wu, Tung-Ho, Wang, Yun-Ming, Cheng, Tian-Lu, Chen, I-Ju, Lu, Yun-Chi, Chuang, Kuo-Hsiang, Wang, Chih-Kuang, Chen, Chiao-Yun, Lin, Rui-An, Chen, Huei-Jen, Liao, Tzu-Yi, Liu, En-Shuo, Chen, Fang-Ming
Publicado 2020

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor acti...

por Ho, Kai-Wen, Chen, I.-J.u, Cheng, Yi-An, Liao, Tzu-Yi, Liu, En-Shuo, Chen, Huei-Jen, Lu, Yun-Chi, Su, Yu-Cheng, Roffler, Steve R., Huang, Bo-Cheng, Liu, Hui-Ju, Huang, Ming-Yii, Chen, Chiao-Yun, Cheng, Tian-Lu
Publicado 2021